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Abstract 
Hsp25 is the murine equivalent of human Hsp27, both of which are members of 
the small heat shock protein (sHsp) family.  sHsps are a group of intracellular 
molecular chaperones that protect unstable intermediates of cellular proteins 
from aggregation and precipitation.  Hsp27 and other sHsps play a role in 
various neurodegenerative diseases such as Alzheimer's, Alexander's, 
Creutzfeld-Jakob and Parkinson's diseases.  Crystallisation of mammalian sHsps 
has thus far not been achieved due to the polydisperse and dynamic nature of 
these proteins.  As a result, the oligomeric structure of sHsps is unclear, 
hindering the elucidation of the functional mechanisms of these proteins. 
In this study, a series of site-directed Hsp25 mutants was constructed, in which 
polar residues of the flexible region of the C-terminal extension were replaced 
with less polar residues.  The C-terminal extension of sHsps is typically short 
and unstructured and is thought to play an important role in solubilising these 
proteins and the complexes they form with target proteins by counteracting the 
hydrophobicity of the remainder of the sHsp.  The C-terminal extension is also 
implicated in interaction with target proteins. 
Wildtype Hsp25 and various C-terminal extension mutants (E190A, R192A, 
Q194A, E199A, E204A, Q205A, K209L) were expressed and successfully 
purified.  A truncation mutant, E190stop, was also constructed but became 
insoluble during the purification process, demonstrating the importance of the 
C-terminal extension in maintaining the stability of Hsp25.  Wildtype and 
 
xvi 
mutant Hsp25 proteins were characterised structurally and functionally using a 
range of spectroscopic techniques, including far-UV circular dichroism 
spectroscopy, tryptophan and ANS binding fluorescence spectroscopy, size-
exclusion fast protein liquid chromatography, nuclear magnetic resonance 
spectroscopy and chaperone assays under both reduction and heat stress 
conditions.  These experiments enabled the identification of residues key to the 
chaperone ability of Hsp25. 
The R192A and Q194A mutants were functionally indistinct from the wildtype 
protein and exhibited only minor alterations to their structure.  It was therefore 
concluded that the R192 and Q194 residues are not vital for Hsp25 to function 
as a molecular chaperone. 
Each of the glutamic acid residue mutants exhibited significant alterations in 
tertiary structure, with increases in exposure of hydrophobic regions compared 
with wildtype Hsp25, and a minor decrease in the oligomeric size of the E190A 
mutant was observed.  Functionally, these mutants showed poor thermostability 
and disrupted chaperone function.  Glutamic acid residues are abundantly 
present in proteins from thermophilic organisms and are implicated in the 
stability of these proteins at high temperatures.  Replacement of each of the 
glutamic acid residues in the C-terminal extension of Hsp25 resulted in loss of 
solubility at elevated temperatures, indicating that these residues perform 
similar roles in both Hsp25 and thermophilic proteins.  The increase in surface 
hydrophobicity may have contributed to the poor thermostability of these 
 
xvii 
mutants and also the inefficient capture of target proteins observed in the 
chaperone assays. 
The tertiary and quaternary structures of the Q205A mutant were significantly 
perturbed and the function of this mutant was completely abolished under heat 
stress conditions.  Alterations to the tertiary structure of the N-terminal domain 
were observed and oligomerisation was severely disrupted, with three distinct 
oligomeric forms being present: an oligomer larger than that of the wildtype 
protein and two smaller oligomers.  The chaperone activity of this mutant was 
comparable to that of wildtype Hsp25 under reduction stress conditions, 
indicating that each of the oligomeric forms were functional.  Under heat stress 
conditions, however, the Q205A mutant co-precipitated along with the target 
proteins.  Flexibility of the mutated residue was considerably decreased, as 
assessed by NMR experiments, but the remainder of the C-terminal extension 
was not significantly altered.  Together, these results lead to the conclusion 
that the Q205 residue is vital for the performance of Hsp25 as a molecular 
chaperone at elevated temperatures. 
Mutation of the K209 residue also showed disruption to the oligomerisation of 
Hsp25, with the K209L mutant eluting as three peaks after size-exclusion 
chromatography.  This mutant was functionally defective under reduction stress 
conditions but showed comparable chaperone activity to the wildtype at high 
temperature, suggesting that the smaller oligomeric species require 
temperature-induced structural alterations in order to acquire chaperone ability.  
Because full chaperone activity was observed under reduction stress conditions, 
 
xviii 
direct interactions between the C-terminal lysine residue of Hsp25 and target 
proteins is unlikely to be a requirement of chaperone activity. 
The stabilisation of αB-crystallin by αA-crystallin is important for the 
maintenance of the structure and function of αB-crystallin in the eye lens, 
where these sHsps are present in a ~3:1 ratio.  Outside the eye lens, however, 
αA-crystallin is found only in trace amounts in some tissues.  Co-complexes 
between various sHsps have been observed in vivo, for example between 
αB-crystallin and Hsp27, and it has been proposed that one or more ubiquitous 
sHsps stabilise αB-crystallin in non-lenticular tissues.  Whilst αB-crystallin was 
found to be unstable above ~69°C, Hsp25 remained almost completely in 
solution at 100°C.  A 3:1 Hsp25:αB-crystallin mixture showed practically 
identical thermostability to the Hsp25 homo-oligomer and provides support for 
the role of this sHsp as a stabiliser of αB-crystallin.  Chaperone activity assays 
of the 3:1 mixture show results closely resembling those of the Hsp25 homo-
oligomer and demonstrate that interactions between the two sHsps result in an 
altered chaperone activity of αB-crystallin. 
Significant insights into the structure and function of Hsp25 were gained in this 
study.  Several residues in the C-terminal extension were identified as critical to 
the structural and functional integrity of this sHsp and analysis of the amino 
acid composition of the C-terminal extensions of sHsps from various organisms 
indicate that some of these residues may play similar roles in other sHsps. 
 
